New suits filed against GSK for patent-extension efforts

05/21/2004 |

Two more lawsuits were filed against GlaxoSmithKline this week, adding to a string of actions against the pharmaceutical industry for alleged efforts to keep generic competitors out of the marketplace. New York City charged federal antitrust violations in suits filed in Virginia and Pennsylvania against GSK, charging the company with "evergreening" its Paxil and Augmentin patents. GSK denied any improprieties, saying the suit is part of a "political climate" that portrays pharmaceutical companies as trying to keep drug prices high.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA